COVID-19-Related Neuropathic Pain: A Systematic Review and Meta-Analysis.
J Clin Med
; 12(4)2023 Feb 20.
Article
in English
| MEDLINE | ID: covidwho-2246339
ABSTRACT
INTRODUCTION:
SARS-CoV-2, responsible for the coronavirus disease (COVID-19) pandemic, may impact other systems apart from the respiratory system, including the nervous system. In this systematic review, we aimed to establish the prevalence and determinants of neuropathic pain amongst COVID-19-infected individuals.METHODOLOGY:
A literature search in the PubMed database was performed and 11 papers were eligible for inclusion in this systematic review and meta-analysis.RESULTS:
The pooled prevalence of COVID-19-related neuropathic pain was 6.7% (95% CI 4.7-9.5%) for hospitalised patients during the acute phase and 34.3% (95% CI 14.3-62%) for long COVID patients. The identified risk factors for COVID-19-related neuropathic pain development included depression, COVID-19 severity and azithromycin use.CONCLUSIONS:
Neuropathic pain is a very common symptom in long COVID, indicating the urgency for further research in this direction.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Long Covid
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
Jcm12041672
Similar
MEDLINE
...
LILACS
LIS